IP Library Granted Patent US 12,070,593
Granted Patent B2
US 12,070,593 · App. 18/117,542 · Granted Aug 27, 2024

Vagal nerve stimulation for treating dopamine-related conditions

Inventors: Bruce J. Simon (Santa Fe, NM); Joseph P. Errico (Palm Beach Gardens, FL); John T. Raffle (Austin, TX)
Assignee: ELECTROCORE, INC
A61N1/0456A61N1/36014A61N1/36021A61N1/36034A61N1/36053A61N1/40A61N2/008A61N2/02H04R25/305H04R25/505H04R25/70A61N1/36075A61N2/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,070,593
App. No.
18/117,542
Granted
Aug 27, 2024
Kind
B2
Abstract

Vagal nerve stimulation devices and methods are provided for treating medical conditions, such as conditions associated with insufficient dopamine and/or endogenous opioids in the brain. A device includes one or more electrodes having a contact surface for contacting an outer skin surface of a patient and an energy source coupled to the electrodes. The energy source generates one or more electrical impulses and transmits the electrical impulses to the electrodes and transcutaneously through the outer skin surface of the patient at or near a vagus nerve. The one or more electrical impulses is sufficient to modulate the vagus nerve and release dopamine and/or endogenous opioids in a brain of the patient.

Claims (25)

1. A device for treating a medical condition in a patient, the device comprising:

one or more electrodes having a contact surface configured for contacting an outer skin surface of a patient; and

a power source coupled to the electrodes, wherein the power source is configured to generate one or more electrical impulses and to transmit the electrical impulses to the electrodes and transcutaneously through the outer skin surface of the patient at or near a vagus nerve, wherein the one or more electrical impulses comprises one or more electrical impulses, wherein the one or more electrical pulses comprise bursts of 2 to 20 pulses within each burst, wherein each burst has a frequency of about 5 Hz to about 100 Hz, wherein the one or more electrical impulses is sufficient to modulate the vagus nerve and to stimulate one or more dopamine-producing neurons in the brain of the patient.

2. The device of claim 1 further comprising a housing, wherein the power source is housed within the housing and the electrodes are coupled to the housing.

3. The device of claim 2 , wherein the one or more electrodes are housed within, or incorporated into, the housing.

4. The device of claim 1 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to produce endogenous opioids or endogenous cannabinoids within the brain of the patient.

5. The method of claim 1 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to release one or more inhibitory neurotransmitters within the brain of the patient.

6. The device of claim 5 , wherein the one or more inhibitory neurotransmitters comprise GABA.

7. The device of claim 5 , wherein the one or more inhibitory neurotransmitters comprise glutamate.

8. The device of claim 1 , further comprising a signal generator coupled to the power source.

9. The device of claim 8 , wherein each burst of pulses comprises a burst period and a constant period, wherein each burst period and constant period together have a combined frequency from about 15 Hz to about 50 Hz, and, wherein the pulses alternate between a positive voltage and a negative voltage within each of the burst periods.

10. The device of claim 9 , wherein each pulse has a duration of about 20 to about 1000 microseconds.

11. The device of claim 9 , wherein the signal generator generates zero pulses during the constant periods.

12. The device of claim 10 , wherein the outer skin surface is a neck of the patient.

13. A method for treating a medical condition in a patient the method comprising:

positioning one or more electrodes in contact with an outer skin surface of a neck of the patient;

generating one or more electrical impulses; and

transmitting the one or more electrical impulses to the one or more electrodes transcutaneously through the outer skin surface of the patient at or near a vagus nerve within the patient, wherein the one or more electrical impulses comprise bursts of 2 to 20 pulses within each burst, wherein each burst has a frequency of about 5 Hz to about 100 Hz, wherein the one or more electrical impulses is sufficient to modulate the vagus nerve and to stimulate one or more dopamine-producing neurons in the brain of the patient.

14. The method of claim 13 , wherein the one or more electrical impulses are generated within a housing and transmitted to the one or more electrodes within the housing.

15. The method of claim 14 , wherein the one or more electrical impulses is generated by further a signal generator.

16. The method of claim 15 , wherein each burst of pulses comprises a burst period and a constant period, wherein each burst period and constant period together have a combined frequency from about 15 Hz to about 50 Hz, and, wherein the pulses alternate between a positive voltage and a negative voltage within each of the burst periods.

17. The method of claim 13 , wherein each pulse has a duration of about 20 to about 1000 microseconds.

18. The method of claim 13 , further comprising generating zero pulses during the constant periods.

19. The method of claim 13 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to release one or more inhibitory neurotransmitters within the brain of the patient.

20. The method of claim 19 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to produce endogenous opioids or endogenous cannabinoids in a brain of the patient.

Assignments (2)
SECURITY INTEREST Recorded Aug 12, 2025
From: ELECTROCORE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 072452/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2023
From: ELECTROCORE, LLC
To: ELECTROCORE, INC
Reel/Frame 062887/0595 →
Continuity (25)
Continuation 17702051 · Mar 23, 2022
Continuation 17461886 · Aug 30, 2021
Continuation 16540435 · Aug 14, 2019
Division 14992921 · Jan 11, 2016
Continuation 14229894 · Mar 29, 2014
Division 13109250 · May 17, 2011
Division 13075746 · Mar 30, 2011
Division 13024727 · Feb 10, 2011
Continuation In Part 13005005 · Jan 12, 2011
Continuation In Part 12964050 · Dec 9, 2010
Continuation In Part 12859568 · Aug 19, 2010
Continuation In Part 12612177 · Nov 4, 2009
Continuation In Part 12408131 · Mar 20, 2009
Continuation In Part 11592095 · Nov 2, 2006
Continuation In Part 11591340 · Nov 1, 2006
Provisional Application 61471405 · Apr 4, 2011
Provisional Application 61451259 · Mar 10, 2011
Provisional Application 61415469 · Nov 19, 2010
Provisional Application 60814313 · Jun 16, 2006
Provisional Application 60814312 · Jun 16, 2006
Provisional Application 60786564 · Mar 28, 2006
Provisional Application 60772361 · Feb 10, 2006
Provisional Application 60736002 · Nov 10, 2005
Provisional Application 60736001 · Nov 10, 2005
Related Publication 20230201569A1 · Jun 29, 2023
Cited By (2)
US 12,357,817 US 12,598,433